therapeutic tumor infiltrating lymphocytes [clinicaltrials_resource:53ade4451a9e77062e422e15f30ce403]
Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma [clinicaltrials:NCT00002535]Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors [clinicaltrials:NCT00002572]Biological Therapy in Treating Patients With Metastatic Cancer [clinicaltrials:NCT00002733]Biological Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00002786]Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00006113]Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00019084]Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy [clinicaltrials:NCT00019357]Biological Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00045149]Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00046852]Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00062036]Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00085462]Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00091104]Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the Lung [clinicaltrials:NCT00301730]Tumor-Infiltrating Lymphocytes in Treating Patients With Persistent or Recurrent B-Cell Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia or Multiple Myeloma After a Previous Donor Stem Cell Transplant [clinicaltrials:NCT00445666]clinicaltrials:NCT00566098
intervention [clinicaltrials_vocabulary:intervention]
therapeutic tumor infiltrating lymphocytes [clinicaltrials_resource:53ade4451a9e77062e422e15f30ce403]
Bio2RDF identifier
53ade4451a9e77062e422e15f30ce403
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:53ade4451a9e77062e422e15f30ce403
intervention name [clinicaltrials_vocabulary:intervention-name]
therapeutic tumor infiltrating lymphocytes
identifier
clinicaltrials_resource:53ade4451a9e77062e422e15f30ce403
title
therapeutic tumor infiltrating lymphocytes
@en
type
label
therapeutic tumor infiltrating ...... de4451a9e77062e422e15f30ce403]
@en